ITCI
Geode Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,831,951
| Closed | -$242M | – | 4573 |
|
2025
Q1 | $242M | Buy |
1,831,951
+115,122
| +7% | +$15.2M | 0.02% | 579 |
|
2024
Q4 | $143M | Buy |
1,716,829
+8,528
| +0.5% | +$712K | 0.01% | 774 |
|
2024
Q3 | $125M | Buy |
1,708,301
+22,128
| +1% | +$1.62M | 0.01% | 839 |
|
2024
Q2 | $116M | Sell |
1,686,173
-379,125
| -18% | -$26M | 0.01% | 837 |
|
2024
Q1 | $143M | Buy |
2,065,298
+63,507
| +3% | +$4.4M | 0.01% | 732 |
|
2023
Q4 | $143M | Buy |
2,001,791
+90,769
| +5% | +$6.5M | 0.02% | 675 |
|
2023
Q3 | $99.6M | Buy |
1,911,022
+74,265
| +4% | +$3.87M | 0.01% | 796 |
|
2023
Q2 | $116M | Buy |
1,836,757
+87,739
| +5% | +$5.56M | 0.01% | 705 |
|
2023
Q1 | $94.7M | Buy |
1,749,018
+77,581
| +5% | +$4.2M | 0.01% | 776 |
|
2022
Q4 | $88.5M | Buy |
1,671,437
+53,127
| +3% | +$2.81M | 0.01% | 782 |
|
2022
Q3 | $75.3M | Buy |
1,618,310
+29,911
| +2% | +$1.39M | 0.01% | 818 |
|
2022
Q2 | $90.7M | Buy |
1,588,399
+117,442
| +8% | +$6.7M | 0.01% | 729 |
|
2022
Q1 | $90M | Buy |
1,470,957
+185,143
| +14% | +$11.3M | 0.01% | 839 |
|
2021
Q4 | $67.3M | Buy |
1,285,814
+13,094
| +1% | +$685K | 0.01% | 1082 |
|
2021
Q3 | $47.4M | Buy |
1,272,720
+19,518
| +2% | +$728K | 0.01% | 1323 |
|
2021
Q2 | $51.2M | Buy |
1,253,202
+58,449
| +5% | +$2.39M | 0.01% | 1286 |
|
2021
Q1 | $40.5M | Buy |
1,194,753
+86,757
| +8% | +$2.94M | 0.01% | 1393 |
|
2020
Q4 | $35.2M | Buy |
1,107,996
+104,632
| +10% | +$3.33M | 0.01% | 1361 |
|
2020
Q3 | $25.7M | Buy |
1,003,364
+160,340
| +19% | +$4.11M | 0.01% | 1337 |
|
2020
Q2 | $21.6M | Buy |
843,024
+36,422
| +5% | +$935K | ﹤0.01% | 1460 |
|
2020
Q1 | $12.4M | Buy |
806,602
+167,104
| +26% | +$2.57M | ﹤0.01% | 1607 |
|
2019
Q4 | $21.9M | Sell |
639,498
-12,873
| -2% | -$442K | ﹤0.01% | 1513 |
|
2019
Q3 | $4.87M | Buy |
652,371
+7,957
| +1% | +$59.4K | ﹤0.01% | 2395 |
|
2019
Q2 | $8.36M | Buy |
644,414
+31,800
| +5% | +$413K | ﹤0.01% | 2072 |
|
2019
Q1 | $7.46M | Buy |
612,614
+88,153
| +17% | +$1.07M | ﹤0.01% | 2093 |
|
2018
Q4 | $5.97M | Buy |
524,461
+25,588
| +5% | +$291K | ﹤0.01% | 2109 |
|
2018
Q3 | $10.8M | Buy |
498,873
+29,754
| +6% | +$646K | ﹤0.01% | 1860 |
|
2018
Q2 | $8.29M | Buy |
469,119
+51,863
| +12% | +$916K | ﹤0.01% | 2024 |
|
2018
Q1 | $8.78M | Buy |
417,256
+16,062
| +4% | +$338K | ﹤0.01% | 1856 |
|
2017
Q4 | $5.81M | Buy |
401,194
+64,005
| +19% | +$927K | ﹤0.01% | 2118 |
|
2017
Q3 | $5.32M | Buy |
337,189
+50,659
| +18% | +$799K | ﹤0.01% | 2171 |
|
2017
Q2 | $3.56M | Buy |
286,530
+15,748
| +6% | +$196K | ﹤0.01% | 2382 |
|
2017
Q1 | $4.4M | Buy |
270,782
+8,023
| +3% | +$130K | ﹤0.01% | 2191 |
|
2016
Q4 | $3.97M | Buy |
262,759
+15,767
| +6% | +$238K | ﹤0.01% | 2208 |
|
2016
Q3 | $3.76M | Buy |
246,992
+26,193
| +12% | +$399K | ﹤0.01% | 2146 |
|
2016
Q2 | $8.57M | Buy |
220,799
+15,863
| +8% | +$616K | ﹤0.01% | 1553 |
|
2016
Q1 | $5.7K | Buy |
204,936
+11,301
| +6% | +$314 | ﹤0.01% | 1786 |
|
2015
Q4 | $10.4M | Buy |
193,635
+25,312
| +15% | +$1.36M | 0.01% | 1353 |
|
2015
Q3 | $6.74M | Buy |
168,323
+3,333
| +2% | +$133K | ﹤0.01% | 1634 |
|
2015
Q2 | $5.27M | Buy |
164,990
+8,329
| +5% | +$266K | ﹤0.01% | 1853 |
|
2015
Q1 | $3.74M | Buy |
156,661
+41,927
| +37% | +$1M | ﹤0.01% | 2033 |
|
2014
Q4 | $2.03M | Buy |
114,734
+2,978
| +3% | +$52.6K | ﹤0.01% | 2425 |
|
2014
Q3 | $1.53M | Buy |
111,756
+35,550
| +47% | +$487K | ﹤0.01% | 2524 |
|
2014
Q2 | $1.28M | Buy |
76,206
+20,431
| +37% | +$344K | ﹤0.01% | 2640 |
|
2014
Q1 | $1.01M | Buy |
+55,775
| New | +$1.01M | ﹤0.01% | 2791 |
|